I have recently been diagnosed with prostate cancer. One blood test showed a PSA level of 13 ng/mL, and a second was 17 ng/mL. So, I underwent a biopsy, which showed adenocarcinoma with a Gleason ...

127 patients underwent prostate biopsy, with 94 prostate cancers diagnosed; 86.2 percent had clinically significant disease.

It's common for healthcare professionals to order biopsies for patients whom they suspect may have prostate cancer. A biopsy doesn't just rule out prostate cancer or show its presence, though.

Transperineal mapping biopsies mitigate these problems but carry increased cost and patient ... significant prostate cancer using a local anaesthetic, transperineal, MRI-targeted biopsy technique.

PROSTATE cancer (PCa) screening through serum PSA testing has been shown to significantly reduce mortality rates. The ...

Investigators assessed whether MRI alone can identify all cases of Gleason grade group 2 or higher disease in patients on ...

Association of PSMA PET results at biochemical recurrence (BCR) with metastasis free survival (MFS) by conventional imaging (CI) in patients with locally advanced or high-risk localized prostate ...

IRE was performed as a day procedure, under general anaesthetic, with the patient placed in the lithotomy position ... of both imaging and biopsy results the prostate was divided into three ...

The urinary 18-gene MyProstateScore 2.0 (MPS2) test can detect clinically significant prostate cancer and reduce the frequency of biopsies compared with the Prostate Cancer Prevention Trial risk ...

I have recently been diagnosed with prostate cancer. One blood test showed a PSA level of 13 ng/mL, and a second was 17 ng/mL. So, I underwent a biopsy, which showed adenocarcinoma with a Gleason ...